PRECLUDE MVP DURA SUBSTITUTE— 510(k) K021477

Name: FDA 510(k) clearance K021477
Creator: U.S. Food and Drug Administration
Published: 2002-11-08

Substantially Equivalent

W. L. Gore & Associates, Inc.

FDA 510(k) clearance K021477 for PRECLUDE MVP DURA SUBSTITUTE, Substantially Equivalent on 2002-11-08. Applicant: W. L. Gore & Associates, Inc.. Device class: 2.

Clearance details

Applicant: W. L. Gore & Associates, Inc.
Product code: Code GXQ
Device class: Class 2
Regulation: 21 CFR 882.5910
Advisory panel: Neurology
Date received: 2002-05-08
Decision date: 2002-11-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Flagstaff, AZ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GXQ

view all

K251191 — Collagen Dura Regeneration Membrane - Repair2025-11-18
K250420 — Helios Dura Regeneration Matrix2025-05-14
K223445 — ArtiFascia2023-08-10
K212943 — SyntheCel Dura Repair2022-01-28
K183513 — XenoSure Dura Biologic Patch2019-06-13

More clearances from W. L. Gore & Associates, Inc.

view all

K250410 — GORE® Tri-Lobe Balloon Catheter2025-06-02
K240083 — GORE® PROPATEN® Vascular Graft2024-03-01
K232312 — GORE® PROPATEN® Vascular Graft2024-01-09
K233551 — GORE® ACUSEAL Vascular Graft2023-12-19
K231505 — GORE® ACUSEAL Vascular Graft2023-06-23

Adverse events under product code GXQ

product code GXQ

Death: 11
Injury: 446
Other: 1
Total: 458

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.